Cancer Immunotherapy Trials Underutilize Immune Response Monitoring

Claire M. Connell,Sophie E.M. Raby,Ian Beh,Thomas R. Flint,Edward Williams,Douglas T. Fearon,Duncan I. Jodrell,Tobias Janowitz

Cancer Immunotherapy Trials Underutilize Immune Response Monitoring

2018

Claire M. Connell
Sophie E.M. Raby
Ian Beh
Thomas R. Flint
Edward Williams
Douglas T. Fearon
Duncan I. Jodrell
Tobias Janowitz

This work was supported by the Wellcome Trust Translational Medicine and Therapeutics Programme [RJAG/076 to T.J], by Cancer Research UK [C42738/A24868 to TJ], and the Cambridge Translational Medicine and Therapeutics Academic Clinical Fellowship Programme (C.M.C).

Keywords:

Cancer immunotherapy
Cancer
Translational medicine
Pathology
Pharmacology
Immunology
Immunotherapy
Immune system
Medicine
Alternative medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations